|
Volumn 17, Issue 11, 2002, Pages 2011-2013
|
Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome
|
Author keywords
Focal segmental glomerulosclerosis; Minimal change nephropathy; Mycophenolate mofetil; Nephrotic syndrome
|
Indexed keywords
AZATHIOPRINE;
CHLORAMBUCIL;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
LEVAMISOLE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
SERUM ALBUMIN;
STEROID;
TACROLIMUS;
DRUG DERIVATIVE;
GLUCOCORTICOID;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID;
ADULT;
ALBUMIN BLOOD LEVEL;
ARTICLE;
CLINICAL ARTICLE;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
FOCAL GLOMERULOSCLEROSIS;
GASTROINTESTINAL SYMPTOM;
HUMAN;
IDIOPATHIC DISEASE;
KIDNEY DISEASE;
LEUKOPENIA;
NEPHROTIC SYNDROME;
PRIORITY JOURNAL;
RELAPSE;
REMISSION;
CLINICAL TRIAL;
LIPOID NEPHROSIS;
MIDDLE AGED;
RECURRENT DISEASE;
ADULT;
GLOMERULOSCLEROSIS, FOCAL SEGMENTAL;
GLUCOCORTICOIDS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MIDDLE AGED;
MYCOPHENOLIC ACID;
NEPHROSIS, LIPOID;
NEPHROTIC SYNDROME;
PREDNISOLONE;
RECURRENCE;
REMISSION INDUCTION;
SERUM ALBUMIN;
|
EID: 0036843138
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/17.11.2011 Document Type: Article |
Times cited : (76)
|
References (9)
|